临床实践指南:共享决策,诊断评估和2型糖尿病的药物治疗
Christina Brockamp1, Rüdiger Landgraf, Ulrich Alfons Müller
1Agency for Quality in Medicine (AZQ), Berlin, Germany; German Diabetes Foundation (DDS), Düsseldorf, Germany; Medical Practice for Endocrinology and Diabetology, Jena, MVZ Dr. med. Kielstein Ambulante Medizinische Versorgung GmbH Erfurt, Germany; Department of Medicine I, University Hospital RWTH Aachen, Germany; Department of Psychosomatic Medicine and Psychotherapy, LWL-University Clinic Bochum, Ruhr-University Bochum, Germany; Center for Psychotherapy Wiesbaden MVZ GmbH; Primary physicians' offices Ittlingen and Neckargmünd, Germany, Specialists in diabetology.
更新的德国2型糖尿病指南强调了共享决策,并考虑了药物治疗中的心血管/风险. GLP-1受体激动剂和SGLT2抑制剂对心血管疾病患者有好处.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病是一种普遍的全球性疾病,几乎每五个65岁以上的德国人中就有一人患有这种疾病.
- 德国国家2型糖尿病疾病管理指南 (NDMG) 提供了最新的诊断和治疗建议.
- 该指南包括基于证据的医学,专家临床意见和患者的观点.
更多相关视频
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Peripheral Artery Disease III: Interprofessional Care
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
